Title:
THERAPEUTIC CHROMONE COMPOUNDS
Document Type and Number:
WIPO Patent Application WO2002055013
Kind Code:
A8
Abstract:
Provided herein is a compound of the formula (I) wherein said compound is useful for the treatment of psychiatric disorders including but not limited to depression, generalized anxiety, eating, disorders, dementia, panic disorder, and sleep disorders. The compounds may also be useful in the treatment of gastrointestinal disorders, cardiovascular regulation, motor disorders, endocrine disorders, vasospasm and sexual dysfunction. The compounds are 5HT 1B antagonists. Also provided herein are processes for making compounds of Formula (I) and intermediate compounds.
Inventors:
CHAPDELAINE MARC (US)
DAVENPORT TIMOTHY (US)
HAEBERLEIN MARKUS (SE)
HORCHLER CAREY (US)
MCCAULEY JOHN (US)
PIERSON EDWARD (US)
SOHN DANIEL (SE)
DAVENPORT TIMOTHY (US)
HAEBERLEIN MARKUS (SE)
HORCHLER CAREY (US)
MCCAULEY JOHN (US)
PIERSON EDWARD (US)
SOHN DANIEL (SE)
Application Number:
PCT/SE2002/000069
Publication Date:
May 13, 2004
Filing Date:
January 15, 2002
Export Citation:
Assignee:
ASTRAZENECA AB (SE)
CHAPDELAINE MARC (US)
DAVENPORT TIMOTHY (US)
HAEBERLEIN MARKUS (SE)
HORCHLER CAREY (US)
MCCAULEY JOHN (US)
PIERSON EDWARD (US)
SOHN DANIEL (SE)
CHAPDELAINE MARC (US)
DAVENPORT TIMOTHY (US)
HAEBERLEIN MARKUS (SE)
HORCHLER CAREY (US)
MCCAULEY JOHN (US)
PIERSON EDWARD (US)
SOHN DANIEL (SE)
International Classes:
A61K31/4025; A61K31/4178; A61K31/452; A61K31/496; A61K31/5375; A61K31/54; C07D215/48; A61K31/551; A61P1/00; A61P9/00; A61P15/00; A61P25/00; A61P25/20; A61P25/22; A61P25/24; A61P25/28; C07B61/00; C07D215/50; C07D311/24; C07D311/58; C07D401/04; C07D401/12; C07D405/04; C07D405/06; C07D405/12; C07D405/14; C07D413/06; C07D413/12; C07D417/12; C07D521/00; (IPC1-7): C07D311/24; C07D405/14; C07D417/14; C07D311/74; A61K31/5377; A61K31/497
Download PDF: